Table 3 Visual assessment on 18F-FDG PET: affected lobes with regions of hyper and/or hypometabolism and increased uptake in basal ganglia

A: Patient details

 Total cases

N = 2

N = 4

N = 6

N = 7

N = 3

N = 1

N = 1

  Frontal anomalies

2

1

1

5

0

0

0

  Temporal anomalies

2

4

3

4

2

1

1

  Parietal anomalies

2

0

0

0

0

1

0

  Occipital anomalies

1

0

1

2

2

0

1

  Increased basal ganglia

0

1

5

5

2

1

1

B: Statistical analysis

 Frontal lobes

Anti-NMDAR

Anti-GABABR

Anti-LGI1

Anti-HU

Anti-GAD65

  Anti-GABABR

p = 0.40

  Anti-LGI1

p = 0.464

p = 1.00

  Anti-HU

p = 1.00

p = 0.242

p = 0.103

  Anti-GAD65

p = 0.40

p = 1.00

p = 1.00

p = 0.167

  Anti-the certain group

p = 1.00

p = 1.00

p = 1.00

p = 0.167

p = 1.00

 Temporal lobes

Anti-NMDAR

Anti-GABABR

Anti-LGI1

Anti-HU

Anti-GAD65

  Anti-GABABR

p = 1.00

  Anti-LGI1

p = 0.464

p = 0.20

  Anti-HU

p = 0.50

p = 0.234

p = 1.00

  Anti-GAD65

p = 1.00

p = 0.429

p = 1.00

p = 1.00

  Anti-the certain group

p = 1.00

p = 1.00

p = 0.50

p = 0.167

p = 1.00

 Parietal lobes

Anti-NMDAR

Anti-GABABR

Anti-LGI1

Anti-HU

Anti-GAD65

  Anti-GABABR

p = 0.067

  Anti-LGI1

p = 0.036*

p = 1.00

  Anti-HU

p = 0.083

p = 1.00

p = 1.00

  Anti-GAD65

p = 0.1

p = 1.00

p = 1.00

p = 1.00

  Anti-the certain group

p = 0.33

p = 1.00

p = 0.50

p = 1.00

p = 1.00

 Occipital lobes

Anti-NMDAR

Anti-GABABR

Anti-LGI1

Anti-HU

Anti-GAD65

  Anti-GABABR

p = 0.33

  Anti-LGI1

p = 0.464

p = 0.048*

  Anti-HU

p = 1.00

p = 0.061

p = 1.00

  Anti-GAD65

p = 1.00

p = 0.429

p = 0.226

p = 0.50

  Anti-the certain group

p = 1.00

p = 0.333

p = 0.464

p = 1.00

p = 1.00

 Basial ganglia

Anti-NMDAR

Anti-GABABR

Anti-LGI1

Anti-HU

Anti-GAD65

  Anti-GABABR

p = 1.00

  Anti-LGI1

p = 0.107

p = 0.190

  Anti-HU

p = 0.167

p = 0.242

p = 1.00

  Anti-GAD65

p = 0.40

p = 0.486

p = 1.00

p = 1.00

  Anti-the certain group

p = 0.333

p = 0.40

p = 1.00

p = 1.00

p = 1.00